FeesSafety
Pluang+

Integra LifeSciences posts 2.3% revenue growth in Q3 2026 despite price target cut by Wells Fargo.

Company Fundamentals
22 Oct 2026
Gordon Thompson
View Source
Neutral
Integra LifeSciences posts 2.3% revenue growth in Q3 2026 despite price target cut by Wells Fargo.

Integra LifeSciences reported a 2.3% revenue increase to $411.2 million in Q3 2026, with diluted earnings per share rising to $0.19 from a loss the previous year. The company generated $96 million in operating cash flow and completed a $2.1 billion debt refinancing to extend repayment deadlines. Despite these positive results, Wells Fargo lowered its price target for the stock from $15 to $13, with shares trading around $11.84, about 9.8% below the new target. The company faced a $7 million revenue impact due to flood damage at its Cincinnati facility. Overall, Integra shows financial resilience and growth amid challenges.

Integra LifeSciences Q3 2026 earnings report shows a 2.3% revenue increase to $411.2 million and a rise in diluted EPS to $0.19. For readers following the health sector, here is Pluang's market snapshot as of Oct 22, 2026 20:11 WIB: out of 150 priced US health stocks, 67 rose and 77 fell. Notable movers include ABCL at USD 11.89 with a 2.86% decrease and 79% buy order activity, ZBH at USD 97.49 up 2.77%, and ABBV at USD 277.45 down 2.55% with 63% sell order activity.

More News

Analyst sets $650 price target for Meta amid concerns over rising AI spending.

Analyst sets $650 price target for Meta amid concerns over rising AI spending.

Scotiabank analyst Nat Schindler set a $650 price target for Meta Platforms, about 6.8% below its then-current price of $697.52. Despite Meta's strong revenue from Facebook, Instagram, and WhatsApp, investor concerns over increased artificial intelli...

Analyst Insights
Bearish
31 minutes ago
UBS keeps Buy on Berkshire Hathaway amid strong cash reserves and strategic investments.

UBS keeps Buy on Berkshire Hathaway amid strong cash reserves and strategic investments.

UBS maintains a Buy rating on Berkshire Hathaway's Class A shares, currently trading near $811,320. The company's diverse portfolio and substantial cash reserves of about $360 billion provide stability and investment flexibility. Investor confidence ...

Analyst Insights
Bullish
35 minutes ago
Barclays misses Q3 earnings estimates despite 12% profit rise and £500M buyback plan

Barclays misses Q3 earnings estimates despite 12% profit rise and £500M buyback plan

Barclays PLC reported Q3 2026 earnings with EPS of $0.66 and revenue of $9.86 billion, both slightly below analyst estimates. Pre-tax profit rose 12% year-over-year to £2.32 billion but missed forecasts due to a 19% decline in fixed-income revenue, p...

Company Fundamentals
Bearish
40 minutes ago
Comfort Systems USA expects strong Q3 2026 growth with $12.85 EPS and $3.4B revenue forecast.

Comfort Systems USA expects strong Q3 2026 growth with $12.85 EPS and $3.4B revenue forecast.

Comfort Systems USA is set to report strong Q3 2026 results, with analysts predicting earnings of $12.85 per share and revenue around $3.40 billion, driven by high demand in data centers and a record $14.06 billion backlog. The company showed robust ...

Company Fundamentals
Bullish
46 minutes ago
Karman boosts AI compute by 60% at NexGen Cloud's Montreal data center using power orchestration tech

Karman boosts AI compute by 60% at NexGen Cloud's Montreal data center using power orchestration tech

Karman has enabled NexGen Cloud to increase AI compute capacity by 60% within the same power budget at its Montreal data center by using its AI-driven power orchestration platform. This technology allows 16 NVIDIA B300 servers to run within the power...

Market News
Bullish
46 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App